Uncovering the vasorelaxant effect induced by vale do São Francisco red wine: A role for nitric oxide

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 6, 2011, Pages 696-701

  Luciano, Melissa N ^a   Ribeiro, Thaís P ^a   França Silva, Maria S ^a   Do Nascimento, Roberto J B ^a   De Jesus Oliveira, Eduardo ^a   França, Karime C ^b   Antunes, Alessandra A ^b   Nakao, Lia S ^b   Aita, Carlos A M ^b   Braga, Valdir A ^a   De Medeiros, Isac A ^a,c  

^a Laboratory of Pharmaceutical Technology   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

nitric oxide; red wine; Vale do S o Francisco; vasorelaxant effect

Indexed keywords

ATROPINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; POLYPHENOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FLUORESCENCE; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; RED WINE; VASODILATATION;

ANIMALS; AORTA; BRAZIL; CELL LINE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FLAVONOIDS; FREEZE DRYING; GUANYLATE CYCLASE; MALE; MESENTERIC ARTERY, SUPERIOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENOLS; RABBITS; RATS; RATS, WISTAR; VASODILATOR AGENTS; WINE;

EID: 79958246155     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318217db1f     Document Type: Article

References (45)

1. Renaud SL, de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet. 1992;339:1523-1526.
2. Goldberg DM, Hahn SE, Parkers JG. Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta. 1995;237: 155-187.
3. Vitrac X, Monti JP, Vercauteren J, et al. Direct liquid chromatographic analyses of resveratrol derivatives and flavanonolols in wines with absorbance and fluorescence detection. Anal Chim Acta. 2002;458: 103-110. (Pubitemid 34273824)
4. Dell'Agli M, Busciala A, Bosisio E. Vascular effects of wine polyphenols. Cardiovasc Res. 2004;63:593-602. (Pubitemid 39078672)
5. Stoclet JC, Chataigneau T, N'Diaye M, et al. Vascular protection by dietary polyphenols. Eur J Pharmacol. 2004;500:299-313. (Pubitemid 39304017)
6. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation. 1995;91:1182-1188.
7. Frankel E, Kanner J, German JB, et al. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 1993; 341:454-457. (Pubitemid 23054518)
8. Corder R, Douthwaite JA, Lees DM, et al. Endothelin-1 synthesis reduced by red wine. Nature. 2001;414:863-864. (Pubitemid 34024728)
9. Albrecth EW, Stegeman CA, Heeringa P, et al. Protective role of endothelial nitric oxide synthase. J Pathol. 2003;199:8-17. (Pubitemid 36061187)
10. Feng AN, Chen YL, Chen YT, et al. Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-Fed rabbits. Circulation. 1999;100:2254-2259.
11. Wallerath T, Polleo D, Li H, et al. Red wine increases the expression of human endothelial nitric oxide synthase. J Am Coll Cardiol. 2003;41: 471-478.
12. Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium dependent vasorelaxing activity of wine and other grape products. Am J Physiol. 1993;265: H774-H778. (Pubitemid 23273620)
13. Andriambeloson E, Kleschyov AL, Muller B, et al. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol. 1997;120:1053-1058. (Pubitemid 27122644)
14. De Moura RS, Miranda DZ, Pinto AC, et al. Mechanism of endotheliumdependent vasodilation and the antihypertensive effect of Brazilian red wine. J Card Pharm. 2004;44:302-309. (Pubitemid 39129447)
15. Lucena APS, Nascimento RJB, Maciel JAC, et al. Antioxidant activity and phenolics content of selected Brazilian wines. J Food Comp Anal. 2010;23:30-36.
16. Altura BM, Altura BT. Differential effects of substrate on drug-induced contractions of rabbit aorta. Am J Physiol. 1970;219:1698-705.
17. Furchgott FF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288: 373-376. (Pubitemid 11169009)
18. Moncada S, Higgs EA. The l-arginine-nitric oxide pathway. N Engl J Med. 1993;29:2002-2012. (Pubitemid 24015045)
19. Garthwaite J, Southam E, Boulton CL, et al. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]- oxadiazolo-[4,3-a]-quinoxalin-1-one. Mol Pharmacol. 1995;48:184-188.
20. Caulfield MP, Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 1998;50:279-290. (Pubitemid 28304029)
21. Kojima H, Nakatsubo N, Kikuchi K, et al. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem. 1998;70:2446-2453.
22. Navarro-Antolin J, Lamas S. Nitrosative stress by cyclosporine A in the endothelium: studies with the NO-sensitive probe diaminofluorescein-2- diacetate using flow cytometry. Nephrol Dial Transpl. 2001;16:(suppl 1): 6-9. (Pubitemid 32492497)
23. Ribeiro TP, Porto DL, Menezes CP, et al. Unraveling the cardiovascular effects induced by alpha-terpineol: a role for the NO-cGMP pathway. Clin Exp Pharmacol Physiol. 2010;37:811-816.
24. Stervboa U, Vanga O, Bonnesenb C. A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chem. 2007;101:449-457.
25. Schini-Kerth VB, Auger C, Kim JH, et al. Nutritional improvement of the endothelial control of vascular tone by polyphenols: role of NO and EDHF. Pflugers Arch. 2010;459:853-862.
26. Stavric B. Antimutagens and anticarcinogens in foods. Food Chem Toxicol. 1994;32:79-90. (Pubitemid 24131124)
27. Letenneur L, Larrieu S, Barberger-Gatea P. Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies. Biom Pharmacother. 2004;58:95-99. (Pubitemid 38264534)
28. Lamuela-Raventos RM, Romero-Perez AI, Waterhouse AL, et al. Direct HPLC analysis of cis and trans-resveratrol and piceid isomers in Spanish red Vitis Vinifera wines. J Agric Food Chem. 1995;43:281-283.
29. Ribeiro de Lima MT,Waffo-Teguo P, Teissedre PL, et al. Determination of stilbenes (trans-astringin, cis- and trans-piceid, and cis- and transresveratrol) in Portuguese wines. J Agric Food Chem. 1999;47:2666-2670. (Pubitemid 29396336)
30. Varache-Lembège M, Teguo PW, Richard T, et al. Structure-activity relationships of polyhydroxystilbene derivatives extracted from Vitis Vinifera cell cultures as inhibitors of human platelet aggregation. Med Chem Res. 2000;10:253-267. (Pubitemid 32108747)
31. Andriambeloson E, Magnier C, Haan-Archipoff G, et al. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr. 1998;128:2324-2333. (Pubitemid 29012979)
32. Vitrac X, Bornet A, Vanderlinde R, et al. Determination of stilbenes (d-viniferin, trans-astringin, trans-piceid, cis- and trans-resveratrol, e-viniferin) in Brazilian wines. J Agric Food Chem. 2005;53:5664-5669. (Pubitemid 41022461)
33. Ndiaye M, Chataigneau T, Chataigneau M, et al. Red wine polyphenols induce EDHF-mediated relaxations in porcine coronary arteries through the redox-sensitive activation of the PI3-kinase/Akt pathway. Br J Pharmacol. 2004;142:1131-1136. (Pubitemid 39093009)
34. Leblais V, Krisa S, Valls J, et al. Relaxation induced by red wine polyphenolic compounds in rat pulmonary arteries: lack of inhibition by NO-synthase inhibitor. Fundam Clin Pharmacol. 2008;22:25-35. (Pubitemid 351171282)
35. Flech M, Schwarz A, Böhm M. Effects of red a white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am J Physiol. 1998;275:H1183-H1190.
36. Soares de Moura R, Costa Viana FS, Souza MA, et al. Antihypertensive, vasodilator and antioxidant effects of a vinifera grape skin extract. J Pharm Pharmacol. 2002;54:1515-1520. (Pubitemid 35331213)
37. Gewaltig MT, Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potentials. Cardiovasc Res. 2002;55:250-260. (Pubitemid 34775275)
38. Rajapakse N, Mattson DL. Role of l-arginine in nitric oxide production in health and hypertension Clin Exper Pharmacol Physiol. 2009;36: 249-255.
39. Alioua A, Tanaka Y, Wallner M, et al. The large conductance, voltagedependent, and calcium-sensitive K+ channel, Hslo, is a target of cGMP dependent protein kinase phosphorylation in vivo. J Biol Chem. 1998; 273:32950-32956. (Pubitemid 28557688)
40. Wanstall JC, Homer KL, Doggrell SA. Evidence for, and importance of, cGMP independent mechanisms with NO and NO donors on blood vessels and platelets. Curr Vasc Pharmacol. 2005;3:41-53. (Pubitemid 40089526)
41. Chiou WF, Chang PC, Chou CJ, et al. Protein constituent contributes to the hypotensive and vasorelaxant activities of cordyceps sinensis. Life Sci. 2000;66:1369-1376.
42. Kang DG, Lee KJ, Choi DH, et al. Vascular relaxation by the methanol extract of sorbus cortex via NO-cGMP pathway. Biol Pharm Bull. 2005; 28:860-864. (Pubitemid 40740656)
43. Nakatsuboa N, Kojimaa H, Kikuchi K, et al. Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofluoresceins. FEBS Lett. 1998;427:263-266. (Pubitemid 28225070)
44. Arribas SM, Daly CJ, González MC, et al. Imaging the vascular wall using confocal microscopy. J Physiol. 2007;584(pt 1):5-9. (Pubitemid 47500536)
45. Leikert JF, Rathel TR, Wohlfart P, et al. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation. 2002;106:1614-1617.